Kanabo Group Plc (KNB.L)

1.8500 0.0000 (0.00%) At close: 04:21PM BST

Kanabo Group Plc

Churchill House
137-139 Brent Street
London NW4 4DJ
United Kingdom

https://www.kanabogroup.com

Sector(s): Healthcare
Industry: Medical Care Facilities
Full-time employees: 23

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Avihu Tamir	CEO & Executive Director	164.91k	N/A	1981
Mr. David Sack	Co-founder	N/A	N/A	N/A
Mr. Assaf Vardimon	CFO & Company Secretary	N/A	N/A	1978
Mr. Suleman Sacranie	Chief Technology Officer	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Kanabo Group Plc engages in the development and distribution of cannabis-derived solutions for medical and wellness products. It operates through Primary Care and Secondary Care segments. The company offers non- tetrahydrocannabinol products for cannabidiol consumers. It also provides cultivation consultancy, research and development, and telemedicine and tele pharma services, as well as develops and distributes formulations; operates ecommerce platform, the Kanabo Store; and operates Treat It, an online clinic that provides mental health treatments. The company offers its products under the Kanabo brand name. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Corporate governance

Kanabo Group Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.